Fifth Annual Symposium on Controversies and Clinical Challenges in Myeloma, Lymphoma, and Leukemia
Arizona Biltmore Resort
Phoenix, AZ
September 19-20, 2008
| 7:30 am | Registration and Continental Breakfast |
| 7:55 am | Welcome and Introductions |
| 8:00 am | Presession Survey |
| 8:05 am | Keynote Presentation: Challenges in New Drug Development in Lymphoma and Other Hematologic Malignancies Thomas Miller |
| Clinical Challenges in Lymphoma Moderator: Thomas Miller |
|
| 8:35 am | Clinical Challenges in Low-Grade Lymphoma Wen-Kai Weng |
| 8:55 am | Clinical Challenges in DLBCL Thomas Miller |
| 9:15 am | Clinical Challenges in MCL André Goy |
| 9:35 am | Clinical Challenges in TCLs Daniel O. Persky |
| 9:55 am | Panel Discussion |
| 10:15 am | Break |
| Controversies in Lymphoma Moderator: Thomas Miller |
|
| Debate: Interim PET Scans Should Be Used to Guide Treatment Decisions in DLBCL |
|
| 10:30 am | PRO Wen-Kai Weng |
| 10:50 am | CON Craig Reeder |
| 11:10 am | Controversies in Maintenance Therapy for Follicular Lymphoma in First Remission Daniel O. Persky |
| 11:30 am | Emerging Agents in Lymphoma André Goy |
| 11:50 am | Postsession Survey and Panel Discussion |
| 12:10 pm | Break to Serve Lunch |
| 1:05 pm | Keynote Presentation: Evolving Treatment Options for Immune Thrombocytopenias Ilene Weitz |
| Clinical Challenges in Myeloid Malignancies Moderator: Dan Douer |
|
| 1:40 pm | Presession Survey |
| 1:45 pm | Clinical Challenges in AML Dan Douer |
| 2:05 pm | Clinical Challenges in Newly Diagnosed CML Michael J. Mauro |
| 2:25 pm | Clinical Challenges in CML Resistant to TKIs Meir Wetzler |
| 2:45 pm | Clinical Challenges in MDS Raoul Tibes |
| 3:05 pm | Molecular Tests in Myeloid Malignancies: When, Who, and How Michael J. Mauro |
| 3:25 pm | Postsession Survey and Panel Discussion |
| 4:00 pm | Tumor Board: Curbside Consultations |
| 5:00 pm | Adjourn |
An educational grant for this activity was provided by: